Elevated suPAR levels at hospital admission in acute heart failure patients are significantly correlated with increased one-year mortality risk.
Does elevated suPAR level at admission predict 365-day all-cause mortality in patients with acute heart failure?
386 patients admitted with acute heart failure (AHF) to the emergency department, median age 76.5 years, 43.5% female, in Denmark.
Measurement of soluble urokinase plasminogen activator receptor (suPAR) levels at hospital admission (stratified as high ≥ 6 ng/ml)
Low suPAR levels (< 6 ng/ml)
365-day all-cause mortalityhard clinical
Elevated suPAR levels at hospital admission in AHF patients are independently associated with increased one-year mortality and outperform CRP for prognostication.
Absolute Event Rate: 0% vs 0%
SuPAR levels measured at hospital admission in AHF patients correlate significantly with one-year mortality risk. Potentially, suPAR could be integrated as a part of an early multimodal prognostication mode of AHF to identify high-risk patients.
Building similarity graph...
Analyzing shared references across papers
Loading...
Aginsha Kandiah
Ida Arentz Taraldsen
Mohammed El-Sheikh
International Journal of Cardiology
Hvidovre Hospital
Amager Hospital
Building similarity graph...
Analyzing shared references across papers
Loading...
Kandiah et al. (Thu,) reported a other. Elevated suPAR levels at hospital admission in acute heart failure patients are significantly correlated with increased one-year mortality risk.
synapsesocial.com/papers/6980fbf6c1c9540dea80db73 — DOI: https://doi.org/10.1016/j.ijcard.2026.134199